Zhende Medical Co., Ltd. (603301.SS)
CNY 19.14
(-0.05%)
CNY 19.14
(-0.05%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 4.12 Billion | 6.13 Billion | 5.09 Billion | 10.39 Billion | 1.86 Billion | 1.42 Billion |
| Cost of Revenue | 2.69 Billion | 3.99 Billion | 3.31 Billion | 5.51 Billion | 1.26 Billion | 980.72 Million |
| Gross Profit | 1.43 Billion | 2.14 Billion | 1.77 Billion | 4.88 Billion | 598.9 Million | 448.12 Million |
| Operating Expenses | 1.05 Billion | 1.16 Billion | 919.19 Million | 1.13 Billion | 362.7 Million | 267.25 Million |
| Selling, General and Administrative Expenses | 896.24 Million | 617.31 Million | 513.31 Million | 627.96 Million | 238.56 Million | 146.67 Million |
| Research and Development Expenses | 138.94 Million | 227 Million | 153.14 Million | 259.71 Million | 50.95 Million | 56.91 Million |
| Other Expenses | 566.99 Million | 318.17 Million | 252.73 Million | 246.52 Million | 73.18 Million | -1.86 Million |
| Cost and Expenses | 3.9 Billion | 5.15 Billion | 4.23 Billion | 6.64 Billion | 1.63 Billion | 1.24 Billion |
| Operating Income | 225.94 Million | 812.8 Million | 821.97 Million | 3.53 Billion | 200.33 Million | 153.41 Million |
| Interest Expense | 30.91 Million | 33.53 Million | 25.07 Million | 18.32 Million | 24.22 Million | 21.93 Million |
| Income Tax Expense | 5.49 Million | 98.7 Million | 99 Million | 561.18 Million | 22.65 Million | 21.67 Million |
| Earnings before Tax | 218.89 Million | 801.71 Million | 819.94 Million | 3.53 Billion | 199.23 Million | 151.55 Million |
| Net Income | 198.39 Million | 679.87 Million | 595.86 Million | 2.54 Billion | 156.89 Million | 130.2 Million |
| Earnings Per Share Basic | 0.74 | 2.87 | 2.64 | 12.50 | 0.80 | 0.72 |
| Earnings Per Share Diluted | 0.74 | 2.87 | 2.63 | 12.50 | 0.80 | 0.72 |
| Weighted Average Shares Outstanding | 268.1 Million | 237.32 Million | 225.7 Million | 203.95 Million | 196 Million | 180.48 Million |
| Weighted Average Shares Outstanding (Diluted) | 268.1 Million | 237.32 Million | 226.56 Million | 203.95 Million | 196 Million | 180.48 Million |
| Gross Margin | 0.35 | 0.35 | 0.35 | 0.47 | 0.32 | 0.31 |
| EBIT Margin | 0.12 | 0.18 | 0.20 | 0.36 | 0.16 | 0.16 |
| Profit Margin | 0.05 | 0.11 | 0.12 | 0.25 | 0.08 | 0.09 |
| EBITDA | 494.73 Million | 1.03 Billion | 990.44 Million | 3.62 Billion | 295.19 Million | 238.57 Million |
| Earnings Before Tax Margin | 0.05 | 0.13 | 0.16 | 0.34 | 0.11 | 0.11 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 1.07 Billion | 1.06 Billion | 963.88 Million | 4.12 Billion | 917.84 Million | 903.05 Million |
| Cost of Revenue | 717.22 Million | 721.48 Million | 628.15 Million | 2.69 Billion | 587.33 Million | 602.16 Million |
| Gross Profit | 356.72 Million | 344.61 Million | 335.72 Million | 1.43 Billion | 330.51 Million | 300.88 Million |
| Operating Expenses | 254.85 Million | 241.65 Million | 240.73 Million | 987.79 Million | 251.81 Million | 217.41 Million |
| Selling, General and Administrative Expenses | 214.3 Million | 203.11 Million | 214.77 Million | - | -158.55 Million | 372.97 Million |
| Research and Development Expenses | 36.42 Million | 31.54 Million | 29.49 Million | - | 28.49 Million | 28.19 Million |
| Other Expenses | -4.12 Million | -6.99 Million | -737.45 Thousand | -7.05 Million | -2.01 Million | -2.59 Million |
| Cost and Expenses | 972.07 Million | 963.13 Million | 868.89 Million | 3.68 Billion | 839.15 Million | 819.57 Million |
| Operating Income | 101.86 Million | 102.96 Million | 85.77 Million | 225.94 Million | -105.59 Million | 67.43 Million |
| Interest Expense | 7.52 Million | 7.78 Million | 8.61 Million | 28.92 Million | 5.89 Million | 6.55 Million |
| Income Tax Expense | 32.8 Million | 20.72 Million | 9.8 Million | 5.49 Million | -12.25 Million | -1.07 Million |
| Earnings before Tax | 182.96 Million | 113.15 Million | 85.03 Million | 218.89 Million | -107.6 Million | 64.84 Million |
| Net Income | 146.35 Million | 87.71 Million | 73.39 Million | 198.39 Million | -102.12 Million | 63.15 Million |
| Earnings Per Share Basic | 0.55 | 0.33 | 0.28 | - | -0.37 | 0.24 |
| Earnings Per Share Diluted | 0.55 | 0.33 | 0.28 | - | -0.37 | 0.24 |
| Weighted Average Shares Outstanding | 266.45 Million | 266.45 Million | 262.13 Million | 268.1 Million | 274.58 Million | 265.1 Million |
| Weighted Average Shares Outstanding (Diluted) | 266.45 Million | 266.45 Million | 262.13 Million | 268.1 Million | 274.58 Million | 265.1 Million |
| Gross Margin | 0.33 | 0.32 | 0.35 | 0.35 | 0.36 | 0.33 |
| EBIT Margin | 0.18 | 0.16 | 0.12 | - | 0.11 | 0.09 |
| Profit Margin | 0.14 | 0.08 | 0.08 | 0.05 | -0.11 | 0.07 |
| EBITDA | 190.49 Million | 172.43 Million | 114.07 Million | - | 97.94 Million | 83.77 Million |
| Earnings Before Tax Margin | 0.09 | 0.10 | 0.09 | 0.05 | -0.12 | 0.07 |
INDORAMA
IBM
ABCP
PMDRF
ENLAY
VO2